News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC – ASCO
Photo from ASCO/LinkedIn
May 2, 2024, 14:30

Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC – ASCO

American Society of Clinical Oncology (ASCO) shared on X:

“Breaking news from the ASCO Plenary Series:

Glecirasib demonstrates encouraging efficacy and safety in KRASG12C-mutated Non- Small Cell Lung Cancer (NSCLC) in phase 2 trial from China.

ASCO Daily News has more.”

Glecirasib

Source: ASCO/X

American Society of Clinical Oncology ASCO ASCO Daily News cancer Glecirasib non small cell lung cancer NSCLC OncoDaily Oncology
Special Coverage
Oncolibrary
Mar 13, 2025, 15:52
New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer
Blog
Mar 13, 2025, 14:28
Judy Medeiros Fitzgerald: Why cancer patients dislike labels like "survivor" and "warrior"
Blog
Mar 13, 2025, 14:26
Join EORTC in Brussels as a Clinical Research Associate
Blog
Mar 13, 2025, 11:07
Yan Leyfman: Phenomenal Grand Rounds by Global Cell Therapy Leader - Katy Rezvani
Blog
Mar 13, 2025, 10:43
Eric Bouffet about My Child Matters project - Foundation S
Blog
Mar 13, 2025, 10:14
Miriam Mutebi: Breast cancer is a growing crisis in Africa
Blog
Mar 13, 2025, 10:06
The Call for Abstract for IUCS25 is open - International Urology Cancer Summit
Science
Mar 13, 2025, 09:32
Myeloma Paper of the Day, March 13th, suggested by Robert Orlowski
Science
Mar 13, 2025, 09:10
George Vlachogiannis: Radical surgery vs RTH for sacral chordoma treatment
Blog
Mar 13, 2025, 09:07
Translating Genomic Discoveries into Therapies with Triparna Sen - GRACE
Blog
Mar 13, 2025, 08:55
The Improving Care of EBC Patients in Europe Investigators Meeting - SPCC
Blog
Mar 13, 2025, 08:44
RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression